COUGH IS PREVALENT IN HIGHER PROPORTION OF OLDER PATIENTS WITH BOTH IDIOPATHIC PULMONARY FIBROSIS AND NON-SPECIFIC INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Saini, G. [1 ]
McKeever, T. [1 ]
Braybrooke, R. [1 ]
Hubbard, R. [1 ]
Jenkins, G. [1 ]
Marshall, R. M. [2 ]
Lukey, P. L. [2 ]
Simpson, J. S. [2 ]
机构：
[1] Univ Nottingham, Nottingham NG7 2RD, England
[2] GSK, Fibrosis DPU, Newcastle, Middx, England
来源：
THORAX | 2014年 / 69卷
关键词：
D O I：
10.1136/thoraxjnl-2014-206260.159
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P9
引用
收藏
页码：A81 / A81
页数：1
相关论文
共 50 条
  • [21] Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients
    Feng, Haoshen
    Zhao, Yabin
    Li, Zhenhua
    Kang, Jian
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
  • [22] Prevalence And Characteristics Of Lung Cancer Among Patients With Interstitial Lung Disease And Idiopathic Pulmonary Fibrosis
    Yoon, J.
    Nouraie, S. M.
    Chen, X.
    Chiarchiaro, J.
    Veraldi, K. L.
    Lindell, K. O.
    Gibson, K. F.
    Kass, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [23] Proportion of idiopathic pulmonary fibrosis among interstitial lung disease in a tertiary care center and its response to treatment
    Puthiyaveettil, Suraj Kozhiparambath
    Edakalavan, Jyothi
    Kumar, Neethu Kesava
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [24] Severity, Predictors, And Impact Of Cough In Idiopathic Pulmonary Fibrosis And Systemic Sclerosis-Associated Interstitial Lung Disease
    Cheng, J.
    Wilcox, P. J.
    Corte, T. J.
    Murphy, D.
    Hague, C. J.
    Ryerson, C. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [25] Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: A potential advantage to patients
    Lok, SS
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (09): : 884 - 890
  • [26] Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
    Takei, Reoto
    Matsuda, Toshiaki
    Fukihara, Jun
    Sasano, Hajime
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Kataoka, Kensuke
    Kimura, Tomoki
    Suzuki, Atsushi
    Furukawa, Taiki
    Fukuoka, Junya
    Johkoh, Takeshi
    Kondoh, Yasuhiro
    FRONTIERS IN MEDICINE, 2023, 10
  • [27] Discriminating Between Non-Specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis at Early Stages: When CPET is Enough?
    Afroditi K. Boutou
    Lung, 2020, 198 : 243 - 244
  • [28] Discriminating Between Non-Specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis at Early Stages: When CPET is Enough?
    Boutou, Afroditi K.
    LUNG, 2020, 198 (01) : 243 - 244
  • [29] Microscopic organizing pneumonia and cellular non-specific interstitial pneumonia are widespread in macroscopically normal-appearing Lung tissue in idiopathic pulmonary fibrosis
    Todd, Nevins W.
    Galvin, Jeffrey R.
    Sachdeva, Ashutosh
    Luzina, Irina G.
    Atamas, Sergei P.
    Burke, Allen P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (11): : 1367 - 1370
  • [30] Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
    Zhang, David
    Adegunsoye, Ayodeji
    Oldham, Justin M.
    Wolters, Paul J.
    Garcia, Christine Kim
    Newton, Chad A.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (01)
12345